“…The largest and most advanced area of medical uses are plant VLP-based self-adjuvanting vaccines (Chackerian, 2007;Crisci et al, 2012;Matić and Noris, 2015;Hefferon, 2018;Balke and Zeltins, 2020;Rybicki, 2020;Santoni et al, 2020) with candidates against COVID-19 in the developmental pipelines of at least two companies (Rosales-Mendoza, 2020), as specified also in this research topic. Similarly, plant viral particles are being evaluated on various technological platforms that gain enhanced or even novel functionality through an integration of multivalent, selectively addressable bionanostructures (Fan et al, 2013;Culver et al, 2015;Koch et al, 2016;Dragnea, 2017;Narayanan and Han, 2017;Chu et al, 2018a;Chen et al, 2019;Wege and Koch, 2020). Uses as templates for inorganic and synthetic compounds have led to biohybrid materials of convincing properties (Douglas and Young, 1998;Bittner et al, 2013;Vilona et al, 2015;Tiu et al, 2016;Wen and Steinmetz, 2016;Lee et al, 2017;Zhang et al, 2018;Eiben et al, 2019), such as high-capacity battery electrodes or spatially ordered dye ensembles for light-harvesting.…”